Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (409)	6/8/1999 10:40:00 AM
From: scaram(o)uche	Respond to of 3158

nice note, thanks. on a different front..... I think it may have been this thread where we discussed the open-market purchase of shares by VCs...... More venture funds are investing in publicly traded companies because they see the low-valued biotech companies as good investments that have less risk than the privately held, early-stage biotech companies that venture funds traditionally finance, said Dave Barry, senior editor of the Venture Capital and Healthcare newsletter. phillynews.com